At two minutes, thirty-nine seconds, Whip It was succinct and fittingly staccato, characteristics that in 1980 propelled the band DEVO to the top of the charts. Now DEVO is cracking a capitalist whip, rewriting the song’s lyrics to tout the unveiling of D-EVO (digital evolved), Fujifilm Medical Systems USA’s new portable flat-panel detector. It is the end of an era.
At two minutes, thirty-nine seconds, Whip It was succinct and fittingly staccato, characteristics that in 1980 propelled the band DEVO to the top of the charts. Now DEVO is cracking a capitalist whip, rewriting the song’s lyrics to tout the unveiling of D-EVO (digital evolved), Fujifilm Medical Systems USA’s new portable flat-panel detector. It is the end of an era.
The company best known for computed radiography has plunged headlong into developing and promoting a product that is the nemesis of CR. When cleared by the FDA, the new Fujifilm portable detector, weighing six pounds and measuring 14 x 17 inches, will retrofit existing film-based radiography rooms better than CR can do. And this detector is only the latest such development by the company. Preceding it were electronic x-ray sensors for digital mammography and radiography.
Some hear in this a death knell for CR. Others see the triumph of pragmatism. I see and hear both. But, for me, despite a decade-long advocacy of flat-panel technology, it is melancholic.
Lost in this transition is the perennial opportunity for me to wonder aloud and in print when the greatest CR advocate of all time would embrace DR. More than a decade has passed since I proclaimed CR on the ropes, a claim that Fuji execs kept assuring me was premature until just a few years ago.
With D-EVO, I can no longer speculate when CR will fade from the limelight; I have been vindicated. And Fujifilm is…celebrating! They are having fun with it, like Geico with its gecko and Aflac with its duck.
DEVO the band is recording lyrics about D-EVO the detector, sung to Whip It, a hit three years before Fuji commercialized the first medical CR system. Things will never be the same for me.
No more ribbing Fuji execs at their trade show booths over how long CR can last and listening to their refrain punctuated with bar charts and line graphs showing the enduring strength of CR. Those days are over. Done. Finished.
“CR was really the cost-effective logical solution for many years and in many situations, but we have seen great demand from our customers and from the market in general to really take advantage of the benefits that DR has to offer: quicker workflow, quicker image availability, improved image quality,” said Penny Maier, marketing director of imaging systems at Fujifilm Medical USA.
“Give the past a slip,” DEVO sings. “Crack that whip.”
FDA Grants Expanded 510(k) Clearance for Xenoview 3T MRI Chest Coil in GE HealthCare MRI Platforms
November 21st 2024Utilized in conjunction with hyperpolarized Xenon-129 for the assessment of lung ventilation, the chest coil can now be employed in the Signa Premier and Discovery MR750 3T MRI systems.
FDA Clears AI-Powered Ultrasound Software for Cardiac Amyloidosis Detection
November 20th 2024The AI-enabled EchoGo® Amyloidosis software for echocardiography has reportedly demonstrated an 84.5 percent sensitivity rate for diagnosing cardiac amyloidosis in heart failure patients 65 years of age and older.
New Study Examines Agreement Between Radiologists and Referring Clinicians on Follow-Up Imaging
November 18th 2024Agreement on follow-up imaging was 41 percent more likely with recommendations by thoracic radiologists and 36 percent less likely on recommendations for follow-up nuclear imaging, according to new research.